SensDx uses cookies to track visits to our website only, no personal information is collected. By continuing to use the site you are agreeing to our use of cookies.
Understood
GrypAlert
Sonokard, SensDx

Quick and efficient COVID-19 screening test

It detects virus presence in the very early phase of infection and gives reliable results in 15 minutes!

Vision

Our vision is to revolutionize medical diagnosis worldwide by providing effective, rapid and easy-to-use tests to detect pathogens causing specific diseases.

Mission

Our mission is to prevent the spreading of bacteria and viruses by detecting pathogens at an early stage of development.

SensDx S.A.

District Court for the Capital City of Warsaw in Warsaw
XIII Commercial Department of the National Court Register

KRS: 0000740748

NIP: 5213679076

REGON: 147422840

Share capital: 100 000 zł (paid in full)

Office

ul. Postępu 14B, 02-676 Warszawa

Offices and laboratories

ul. Kładki 24, 80-822 Gdańsk

ul. Bierutowska 57-59, 51-317 Wrocław
(Wrocławski Park Biznesu 3)

ul. Nałęczowska 14, 20-701 Lublin

Mailing Address

ul. Kładki 24, 80-822 Gdańsk

office@sensdx.eu

International Sales & Distribution

+48 531 022 345

sales@sensdx.eu

Click here for more information about international distribution

CEE Region Sales

Poland, Czech Republic, Slovakia, Hungary

+48 576 939 000

sales-cee@sensdx.eu

Media

+48 535 496 885

media@sensdx.eu

Accounting

invoices@sensdx.eu

Foreign currency accounts:

PLN: PL 72 1240 6410 1111 0010 6100 8930

EUR: PL 04 1240 1112 1978 0010 9610 3439

USD: PL 94 1240 1112 1787 0011 0139 2049